The ABCA1 cholesterol transporter associates with one of two distinct dystrophin-based scaffolds in Schwann cells

GLIA

Volumn 56, Issue 6, 2008, Pages 611-618

  Albrecht, Douglas E ^a,c   Sherman, Diane L ^b   Brophy, Peter J ^b   Froehner, Stanley C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Jain Foundation Inc   (United States)

Author keywords

ABCA1; Dystrophin; Myelination; Schwann cell; Syntrophin

Indexed keywords

ABC TRANSPORTER A1; CELL MEMBRANE PROTEIN; DYSTROBREVIN; DYSTROPHIN; GLYCOPROTEIN; ISOPROTEIN; PERIAXIN; PROTEIN DP116; PROTEIN DRP2; SYNTROPHIN; UTROPHIN; ABC TRANSPORTER; CALCIUM BINDING PROTEIN; DYSTROPHIN ASSOCIATED PROTEIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; SYNTROPHIN ALPHA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COILED BODY; COMPLEX FORMATION; CONTROLLED STUDY; MOUSE; NERVE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; RAT; SCHWANN CELL; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL MEMBRANE; CYTOLOGY; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE MUTANT; PHYSIOLOGY; SCIATIC NERVE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCIUM-BINDING PROTEINS; CELL MEMBRANE; DYSTROPHIN; DYSTROPHIN-ASSOCIATED PROTEINS; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; RATS; RATS, WISTAR; SCHWANN CELLS; SCIATIC NERVE;

EID: 45549096100     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20636     Document Type: Article

References (60)

1. Adams ME, Butler MH, Dwyer TM, Peters MF, Murnane AA, Froehner SC. 1993. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11:531-540.
2. Adams ME, Kramarcy N, Fukuda T, Engel AG, Sealock R, Froehner SC. 2004. Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms. J Neurosci 24:10302-10309.
3. Adams ME, Kramarcy N, Krall SP, Rossi SG, Rotundo RL, Sealock R, Froehner SC. 2000. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J Cell Biol 150:1385-1398.
4. Adams ME, Mueller HA, Froehner SC. 2001. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol 155:113-122.
5. Albrecht DE, Froehner SC. 2002. Syntrophins and dystrobrevins: Defining the dystrophin scaffold at synapses. Neurosignals 11:123-129.
6. Albrecht DE, Froehner SC. 2004. DAMAGE, a novel α-dystrobrevin-associated MAGE protein in dystrophin complexes. J Biol Chem 279:7014-7023.
7. Alessi A, Bragg AD, Percival JM, Yoo J, Albrecht DE, Froehner SC, Adams ME. 2006. Gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins. Exp Cell Res 312:3084-3095.
8. Amiry-Moghaddam M, Xue R, Haug FM, Neely JD, Bhardwaj A, Agre P, Adams ME, Froehner SC, Mori S, Ottersen OP. 2004. Alpha-syntrophin deletion removes the perivascular but not endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia. FASEB J 18:542-544.
9. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. 2001. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241.
10. Bewick GS, Nicholson LV, Young C, O'Donnell E, Slater CR. 1992. Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport 3:857-860.
11. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buehler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351.
12. Bragg AD, Amiry-Moghaddam M, Ottersen OP, Adams ME, Froehner SC. 2006. Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on α-syntrophin. Glia 53:879-890.
13. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and αl-syntrophin mediated by PDZ domains. Cell 84:757-767.
14. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J Jr, Hayden MR. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345.
15. Buechler C, Boettcher A, Bared SM, Probst MC, Schmitz G. 2002. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a -syntrophin/utrophin complex. Biochem Biophys Res Commun 293:759-765.
16. Byers TJ, Kunkel LM, Watkins SC. 1991. The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol 115:411-421.
17. Byers TJ, Lidov HG, Kunkel LM. 1993. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81.
18. Cai H, Erdman RA, Zweier L, Chen J, Shaw JHt, Baylor KA, Stecker MM, Carey DJ, Chan YM. 2007. The sarcoglycan complex in Schwann cells and its role in myelin stability. Exp Neurol 205:257-269.
19. Ceccarini M, Grasso M, Veroni C, Gambara G, Artegiani B, Macchia G, Ramoni C, Torreri P, Mallozzi C, Petrucci TC, Macioce P. 2007. Association of dystrobrevin and regulatory subunit of protein kinase A: A new role for dystrobrevin as a scaffold for signaling proteins. J Mol Biol 371:1174-1187.
20. Connors NC, Adams ME, Froehner SC, Kofuji P. 2004. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via α-syntrophin in glia. J Biol Chem 279:28387-28392.
21. Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ. 2004. Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191-195.
22. Engel WK, Dorman JD, Levy RI, Fredrickson DS. 1967. Neuropathy in tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. Arch Neurol 17:1-9.
23. Fabbrizio E, Latouche J, Rivier F, Hugon G, Mornet D. 1995. Re-evaluation of the distributions of dystrophin and utrophin in sciatic nerve. Biochem J 312 (Part 1):309-314.
24. Froehner SC, Murnane AA, Tobler M, Peng HB, Sealock R. 1987. A postsynaptic Mr 58,000 (58K) protein concentrated at acetylcholine receptor-rich sites in Torpedo electroplaques and skeletal muscle. J Cell Biol 104:1633-1646.
25. Gee SH, Madhavan R, Levinson SR, Caldwell JH, Sealock R, Froehner SC. 1998. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci 18:128-137.
26. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, Sanes JR. 1999. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1:215-220.
27. Hogan A, Shepherd L, Chabot J, Quenneville S, Prescott SM, Topham MK, Gee SH. 2001. Interaction of γ 1-syntrophin with diacylglycerol kinase-ζ. Regulation of nuclear localization by PDZ interactions. J Biol Chem 276:26526-26533.
28. Imamura M, Araishi K, Noguchi S, Ozawa E. 2000. A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 9:3091-3100.
29. Kachinsky AM, Froehner SC, Milgram SL. 1999. A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells. J Cell Biol 145:391-402.
30. Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P. 1993. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 52:119-128.
31. Kramarcy NR, Sealock R. 2000. Syntrophin isoforms at the neuromuscular junction: Developmental time course and differential localization. Mol Cell Neurosci 15:262-274.
32. Kramarcy NR, Vidal A, Froehner SC, Sealock R. 1994. Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem 269:2870-2876.
33. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104:R25-R31.
34. Leonoudakis D, Conti LR, Anderson S, Radeke CM, McGuire LM, Adams ME, Froehner SC, Yates JR III, Vandenberg CA. 2004. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J Biol Chem 279:22331-22346.
35. Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS. 1999. Interactions between β 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 2:611-617.
36. Luo S, Chen Y, Lai KO, Arevalo JC, Froehner SC, Adams ME, Chao MV, Ip NY. 2005. (Alpha)-Syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA4 signaling in an ARMS-dependent manner. J Cell Biol 169:813-824.
37. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, de Wet J, Broccardo C, Chimini G, Francone OL. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 97:4245-4250.
38. Mizuno Y, Thompson TG, Guyon JR, Lidov HG, Brosius M, Imamura M, Ozawa E, Watkins SC, Kunkel LM. 2001. Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin. Proc Natl Acad Sci USA 98:6156-6161.
39. Munehira Y, Ohnishi T, Kawamoto S, Furuya A, Shitara K, Imamura M, Yokota T, Takeda S, Amachi T, Matsuo M, Matsuo M, Kioka N, Ueda K. 2004. Alphal-syntrophin modulates turnover of ABCA1. J Biol Chem 279:15091-15095.
40. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME. 2001. Syntrophin-dependent expression and localization of aquaporin-4 water channel protein. Proc Natl Acad Sci USA 98:14108-14113.
41. +-binding protein. Biochemistry 36:1295-1305.
42. Newey SE, Benson MA, Ponting CP, Davies KE, Blake DJ. 2000. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Curr Biol 10:1295-1298.
43. Newey SE, Gramolini AO, Wu J, Holzfeind P, Jasmin BJ, Davies KE, Blake DJ. 2001a. A novel mechanism for modulating synaptic gene expression: differential localization of α-dystrobrevin transcripts in skeletal muscle. Mol Cell Neurosci 17:127-140.
44. Newey SE, Howman EV, Ponting CP, Benson MA, Nawrotzki R, Loh NY, Davies KE, Blake DJ. 2001b. Syncoilin, a novel member of the intermediate filament superfamily that interacts with α-dystrobrevin in skeletal muscle. J Biol Chem 276:6645-6655.
45. Oak SA, Russo K, Petrucci TC, Jarrett HW. 2001. Mouse α1-syntrophin binding to Grb2: Further evidence of a role for syntrophin in cell signaling. Biochemistry 40:11270-11278.
46. Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore SA, Chen ZL, Strickland S, Di Muzio A, Ureini A, Wrabetz A, Feltri ML. 2005. Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci 25:9418-9427.
47. Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, Freeman MW. 2005. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of β1-syntrophin in cholesterol efflux. J Biol Chem 280:39653-39664.
48. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G, Schmitz G. 2000. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 24:192-196.
49. Ort T, Maksimova E, Dirkx R, Kachinsky AM, Berghs S, Froehner SC, Solimena M. 2000. The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of β2-syntrophin and nNOS in pancreatic β-cells. Eur J Cell Biol 79:621-630.
50. Peters MF, Adams ME, Froehner SC. 1997a. Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol 138:81-93.
51. Peters MF, Kramarcy NR, Sealock R, Froehner SC. 1994. Beta 2-Syntrophin: Localization at the neuromuscular junction in skeletal muscle. Neuroreport 5:1577-15780.
52. Peters MF, O'Brien KF, Sadoulet-Puccio HM, Kunkel LM, Adams ME, Froehner SC. 1997b. Beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J Biol Chem 272:31561-31569.
53. Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, Sanes JR, Sealock R, Froehner SC. 1998. Differential membrane localization and intermolecular associations of α-dystrobrevin isoforms in skeletal muscle. J Cell Biol 142:1269-1278.
54. Pollock M, Nukada H, Frith RW, Simcock JP, Allpress S. 1983. Peripheral neuropathy in Tangier disease. Brain 106 (Part 4):911-928.
55. Rust S, Rosier M, Funks H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefte P, Assmann G. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-355.
56. Saito F, Masaki T, Saito Y, Nakamura A, Takeda S, Shimizu T, Toda T, Matsumura K. 2007. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice. J Neurochem 101:1712-1722.
57. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
58. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ. 2001. Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677-687.
59. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K. 1994. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352:49-53.
60. Zuchner S, Sperfeld AD, Senderek J, Sellhaus B, Hanemann CO, Schroder JM. 2003. A novel nonsense mutation in the ABC1 gene causes a severe syringomyelia-like phenotype of Tangier disease. Brain 126(Part 4):920-927.